|
|
|
Clinical Trials at Wake Forest University
Phase II Study of Capecitabine in Patients With Malignant Mesothelioma
Phase I Study ofSS1(dsFv)-PE38 Immunotoxin in Patients With
Advanced Malignancies That Express Mesothelin